Bayer AG closes acquisition of Monsanto in 2018
In 2018, Bayer announced the acquisition of Monsanto, creator of "Roundup" and many other successful pesticides, for $63.0 million. At the time, Monsanto was a promising pesticide and seed manufacturer. The next few years, though, have spelt disaster for the deal. The deal has resulted in a 30.0% loss in value for Bayer, one of the worst acquisitions since Time Warner purchased AOL. Bayer was saddled with class-action lawsuits from Monsanto's unsafe products, ranging from DDT and Agent Orange to Roundup. Bayer has since sold off its animal health segment to Elanco.
StructuralIn response to volatile demand in the wake of the first COVID-19 surge, the company undertook a comprehensive cost reduction program, aimed at shoring up labor and supply costs.
Lorem Ipsum text header Report Title
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Maecenas non leo lacinia, consectetur ipsum non, pretium augue. Vestibulum accumsan dignissim massa, eu scelerisque mi malesuada ut. Aliquam scelerisque facilisis nisl ac varius. Nunc luctus nunc vel eros iaculis, vitae tristique ante fringilla. Ut vitae vulputate est, vel lacinia nisi. Curabitur eget nulla vitae mi faucibus imperdiet. Cras sagittis arcu eu diam pharetra iaculis eget sit amet risus. Morbi eget turpis ut diam commodo congue id eu lacus.
Cras sagittis arcu eu diam pharetra iaculis eget sit amet risus. Morbi eget turpis ut diam commodo congue id eu lacus.
